CLU and Alzheimer disease: Clusterin was also found to have high immunoreactivity in the arterioles and capillaries of AD and CAA patients, indicating clusterin is more likely to co-locate with Aβ40 rather than Aβ42, so that clusterin might mediate the elimination of Aβ40 through perivascular drainage pathway and be involved in CAA pathology [35].